CMS to cover second COVID-19 booster without cost to eligible individuals
![Syringe in vial.](/sites/default/files/styles/900x400/public/2022-04/aha-covid-vaccine-syringe-in-vial-900x400.jpg?itok=SOZx6HQw)
Medicare and Medicaid will cover a second Pfizer or Moderna COVID-19 booster at no cost to eligible enrollees, the Centers for Disease Control and Prevention announced today. Health care providers participating in the Centers for Disease Control and Prevention’s COVID-19 Vaccination Program also must provide authorized COVID-19 vaccines at no cost to recipients.
On March 29, the Food and Drug Administration authorized and CDC recommended a second Pfizer or Moderna COVID-19 vaccine booster dose for adults aged 50 and older at least four months after an initial booster dose. The agencies also authorized and recommended a second Moderna booster dose for certain immunocompromised adults, and a second Pfizer booster dose for certain immunocompromised individuals aged 12 or older.